Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.7 USD | -2.33% |
|
-4.16% | -7.14% |
02:05pm | Avantor, Inc. Announces New J. T. Baker Cell Lysis Solution and J. T. Baker Endonuclease | CI |
06-28 | Barclays Cuts Price Target on Avantor to $25 From $28, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.14% | 14.4B | |
-6.50% | 181B | |
-6.08% | 101B | |
-5.53% | 67.54B | |
-10.42% | 45.09B | |
+8.60% | 44.37B | |
+5.36% | 40.7B | |
+12.56% | 29.85B | |
+10.26% | 24.49B | |
-8.07% | 23.99B |
- Stock Market
- Equities
- AVTR Stock
- News Avantor, Inc.
- Avantor Q3 Adjusted EPS, Revenue Rise Year on Year